CReATe Author Series Ep. 8 Part I - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS

CReATe Podcast
12/06/2023 20 min
CReATe Author Series Ep. 8 Part I - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS

Listen "CReATe Author Series Ep. 8 Part I - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS"

Descargar episodio Ver en sitio original

Episode Synopsis

Dr. Martin Turner is a Professor of Clinical Neurology & Neurosciences at the University of Oxford and Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. They will be discussing their recent publication “Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal”, and the potential role of NfL as a biomarker for ALS. This is part I of a two part series.

More episodes of the podcast CReATe Podcast

ALS Untangled Series Ep. 62 - Ashwagandha 20/10/2025
CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALS 24/09/2025
ALS Untangled Series Ep. 61 - Zinc 09/09/2025
CReATe Author Series Ep. 15 - Drs. Terry Heiman-Patterson and Michael Benatar on Clinical Guidance for ALS/FTD at-risk carriers 02/06/2025
CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS 01/05/2025
CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS 18/02/2025
CReATe Author Series Ep. 12 - Drs. Jesse Crayle and Evadnie Rampersaud on Genetics and ALS Reversal Phenotype 02/01/2025
ALS Untangled Series Ep. 60 - Nuedexta 04/12/2024
ALS Untangled Series Ep. 59 - Lions Mane 04/11/2024
ALS Untangled Series Ep. 58 - Insulin 01/10/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA